MetaCap

Dyne Therapeutics Inc. Company Profile

NASDAQ: DYNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

15.50-0.53 (-3.31%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Dyne Therapeutics at a glance

Dyne Therapeutics Inc. (NASDAQ: DYN) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Waltham, MA. Dyne Therapeutics is led by Mr. John G. Cox M.B.A. and employs about 322 people. The company's shares have traded publicly since 2020.

At a market capitalization of $2.90 billion, it is considered a mid-cap company. Its SEC Central Index Key (CIK) is 0001818794, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Dyne Therapeutics do?

Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

Business description based on the company's public filings.

Company information

Legal name
Dyne Therapeutics Inc.
Ticker
NASDAQ: DYN
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. John G. Cox M.B.A.
Employees
322
Headquarters
1560 Trapelo Road, Waltham, MA, United States
Phone
781 786 8230
IPO year
2020
SEC CIK
0001818794

Companies similar to Dyne Therapeutics

DYN peer companies
CompanyPrice% ChgMarket capCompare
ACADACADIA Pharmaceuticals Inc.17.11-2.73%$2.96Bvs DYN
LEGNLegend Biotech Corporation ADR15.25-5.28%$2.96Bvs DYN
TLXTelix Pharmaceuticals Limited ADR8.37-3.90%$2.84Bvs DYN
SLSSELLAS Life Sciences Group Inc.13.66-8.08%$2.78Bvs DYN
BHCBausch Health Companies Inc.8.22-3.97%$3.08Bvs DYN
XERSXeris Biopharma Holdings Inc.16.97+2.11%$3.10Bvs DYN
VKTXViking Therapeutics Inc.24.77-4.14%$3.16Bvs DYN
ABCLAbCellera Biologics Inc.9.69-7.45%$3.16Bvs DYN

Related